Pharmaceutical companies are on an M&A spree that could break records this year as they look for novel drug and ...

Rising drug spending has generated concern among purchasers and policymakers. This paper compares drug cost growth in a capitated system with that in managed care systems that generally did not place ...

Corporate America may be retreating from its environmental, social and governance goals owing to fears of a backlash. But the latest evidence suggests an abundance of pro-ESG sentiment within the ...

Purdue Pharma is inextricably linked with the opioid crisis. Owned by the Sackler family, the company is known for aggressively and deceptively marketing opioids —OxyContin in particular—to ...

Pharma marketers should include healthcare equity in their media campaigns, concludes a new research report from WPP healthcare agency CMI Media Group. “By keeping diverse communities informed about ...

All study objectives met MRX1 well tolerated, Phase 2 dosing on track to start H2 2026 Data reinforces case for therapeutic doses of MRX1 Oral SolutionFurther confidence on regulatory and clinical ...

Two distinct reports are shedding light on the struggles that pharmaceutical companies face in working with healthcare providers – and showing how mHealth might make their jobs easier. A joint study ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: Pherecydes Pharma (FR0011651694 – ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or ...

Climate change-driven weather disasters like hurricanes, wildfires and floods pose an immediate threat to the U.S. drug supply chain, a new study says. Nearly two-thirds of all U.S. pharmaceutical ...

A pharmaceutical company upgraded its lyophilizer to integrate with a centralized SCADA system, enabling unified reporting, centralized user management and easier maintenance across all plant ...

Medicus Pharma Ltd. announced promising interim results from its SKNJCT-003 Phase 2 clinical study aimed at the non-invasive treatment of basal cell carcinoma (BCC) using the investigational product D ...

ROCKVILLE, Md. and SUZHOU, China, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage ...